SCHLAGWORTE: Impact Life Sciences
Pioneering brain-computer interfaces
Freiburg-based CorTec GmbH has achieved a significant milestone in neurotechnology: this summer, the company’s Brain Interchange™ system was implanted in a patient in the...
‘No patient should have to be ventilated by guesswork’
Originating from years of research at TU Munich, Ebenbuild creates digital twins of the human lung to personalise treatment in critical care. CEO Kei...
The right tools to overcome a difficult start
German medtech and diagnostics start-ups face a number of challenges for raising seed and venture capital. Early networks with industry leaders and end customers...
Biotech Start-up RNhale gewinnt Golden Ticket für BioM-Inkubator MAxL
Das 2023 gegründete RNhale GmbH sichert sich ein Jahr lang kostenfreies Forschen im Martinsrieder Life-Science-Inkubator MAxL. Das vom global agierenden Pharma-unternehmen Daiichi Sankyo ausgelobte Golden Ticket...
Captain T Cell sichert sich erfolgreich Finanzierungsrunde
Das Biotechnologieunternehmen Captain T Cell (Berlin), das TCR-T-Zelltherapien der nächsten Generation für solide Tumore entwickelt, gab den erfolgreichen Abschluss einer Eigenkapitalfinanzierungsrunde mit neuen und...
‘AI is no longer hype – it’s the new infrastructure of...
AI is transforming the life sciences from buzzword to backbone. From Göttingen
to Munich, start-ups use it to accelerate drug discovery, boost precision, and even
model...
4TEEN4 erweitert Series-C-Finanzierungsrunde auf 55 Mio. EUR
Die 4TEEN4 Pharmaceuticals GmbH („4TEEN4“) gibt die Erweiterung ihrer Series-C-Finanzierung auf 55 Mio. EUR bekannt, an der sich bestehende und neue Investoren beteiligen. Das...
‘Out of the lab, straight to the market’
The life sciences sector is regarded as one of the most promising growth markets of the future. Germany is a hightech nation, and its...
Enabling Discovery: How WuXi AppTec’s Crelux Accelerates Biotech Innovation
At Crelux, a WuXi AppTec company in Munich, innovation starts with access. Through strategic collaborations and state-of-the-art technology, Crelux enables start-ups and biotechs to...
‘We aim to set new standards in respiratory medicine with ATL-105’
AATec develops new therapeutics for inflammatory lung diseases based on a new recombinant version of alpha-1 antitrypsin. Backed by a pre-series A funding round...
Now online: Impact Life Sciences 04/2025!
In the newest Impact Life Sciences Special, we explore current technology trends – this time with a focus on medical technology. Industry experts provide...
A golden era for drugs and devices
The global obesity crisis has evolved into one of the most significant healthcare
challenges of the 21st century. With over one billion people worldwide now...
‘What drives me is the vision to transform cancer care worldwide’
Theranostics, with its special subfield called radiotheranostics, is an innovative
approach that combines diagnostic imaging and targeted therapy using radionuclides to detect and treat cancer,...
Now online: The Impact Life Sciences Network
Our WHO IS WHO offers insight into the scene and its players, as well as initial guidance in your search for the right contacts...
Austria’s innovative life sciences scene: watch out for these companies, start-ups,...
Austria has earned an outstanding reputation as a research and production location in the life sciences – thanks to the synergy between top research...